BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiò A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R; Piemonte and Valle d'Aosta Register for Guillain-Barré Syndrome. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology 2003;60:1146-50. [PMID: 12682322 DOI: 10.1212/01.wnl.0000055091.96905.d0] [Cited by in Crossref: 132] [Cited by in F6Publishing: 171] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Minamino M, Miyamoto K, Kuwahara M, Yoshikawa K, Koh J, Kusunoki S, Nagai Y, Ito H. Characteristics of Guillain-Barré syndrome in super-elderly individuals. J Neurol 2023. [PMID: 36645487 DOI: 10.1007/s00415-023-11567-8] [Reference Citation Analysis]
2 Görgülü Ü, Geçer B, Bilen Ş, Kolcu G. Early Disability Predictors of Guillain–Barre Syndrome. SDÜ Tıp Fakültesi Dergisi 2022. [DOI: 10.17343/sdutfd.1188650] [Reference Citation Analysis]
3 López-hernández JC, Galnares-olalde JA, Jorge de Saráchaga A, Briseño-godínez ME, Pérez-valdez E, May-mas RN, Arista-ramírez JL, Bazán-rodríguez L, León-manriquez E, Burgos-centeno J, Vargas-cañas ES. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci 2022;43:3923-3928. [DOI: 10.1007/s10072-021-05834-7] [Reference Citation Analysis]
4 Patel P, Shah D, Jani C, Shah J, Jani R, Kelaiya A, Pandya J, Singh H, Al Omari O, Roy D, Behlau I, Parikh A. Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India. BMC Neurol 2022;22:151. [PMID: 35459157 DOI: 10.1186/s12883-022-02676-4] [Reference Citation Analysis]
5 Arnold LM, Hehir MK, Tandan R, Kolb N, Waheed W. Neck Flexion Strength as a Predictor of Need for Intubation in Guillain-Barre Syndrome. J Clin Neuromuscul Dis 2022;23:119-23. [PMID: 35188907 DOI: 10.1097/CND.0000000000000365] [Reference Citation Analysis]
6 Zheng P, Tian DC, Xiu Y, Wang Y, Shi FD. Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study. Lancet Reg Health West Pac 2022;18:100302. [PMID: 35024648 DOI: 10.1016/j.lanwpc.2021.100302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kaeley N, Kabi A, Pillai A, Shankar T, Ameena M S S. Post-COVID-19 Guillain-Barré Syndrome: A Case Report With Literature Review. Cureus 2022;14:e21246. [PMID: 35178309 DOI: 10.7759/cureus.21246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Holtz BO, Grimm A, Axer H. Patients' attitude towards vaccination after Guillain Barré syndrome. Health Sci Rep 2021;4:e469. [PMID: 34984239 DOI: 10.1002/hsr2.469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Szewczyk AK, Skrobas U, Jamroz-Wiśniewska A, Mitosek-Szewczyk K, Rejdak K. Facial Diplegia-Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review. Healthcare (Basel) 2021;9:1492. [PMID: 34828542 DOI: 10.3390/healthcare9111492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Lin J, Gao Q, Xiao K, Tian D, Hu W, Han Z. Efficacy of therapies in the treatment of Guillain-Barre syndrome: A network meta-analysis. Medicine (Baltimore) 2021;100:e27351. [PMID: 34731107 DOI: 10.1097/MD.0000000000027351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Yonezawa N, Jo T, Matsui H, Fushimi K, Yasunaga H. Effect of Early Tracheostomy on Mortality of Mechanically Ventilated Patients with Guillain-Barré Syndrome: A Nationwide Observational Study. Neurocrit Care 2020;33:759-68. [PMID: 32291575 DOI: 10.1007/s12028-020-00965-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Aragonès J, Altimiras J, Alonso F, Celedón G, Alfonso S, Roura P, Moreira A. Incidence and clinical characteristics of Guillain-Barré syndrome in Osona (Barcelona, Spain), 2003-2016. Neurología (English Edition) 2021;36:525-530. [DOI: 10.1016/j.nrleng.2018.03.020] [Reference Citation Analysis]
13 Aragonès J, Altimiras J, Alonso F, Celedón G, Alfonso S, Roura P, Moreira A. Incidencia y características clínicas del síndrome de Guillain-Barré en la comarca de Osona (Barcelona, España) (2003-2016). Neurología 2021;36:525-530. [DOI: 10.1016/j.nrl.2018.03.021] [Reference Citation Analysis]
14 Skornyakova EA, Zaslavskii LG. Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region. Neuromuscular Diseases 2021;11:39-46. [DOI: 10.17650/2222-8721-2021-11-1-39-46] [Reference Citation Analysis]
15 Ratih Dwi Andini, Darto Saharso, Prastiya Indra Gunawan. Faktor Risiko Disabilitas Berat pada Anak dengan Guillain-Barre Syndrome di RSUD Dr. Soetomo Surabaya. MEDICINUS 2021;34:23-31. [DOI: 10.56951/medicinus.v34i1.48] [Reference Citation Analysis]
16 Kim AY, Lee H, Lee YM, Kang HY. Epidemiological Features and Economic Burden of Guillain-Barré Syndrome in South Korea: A Nationwide Population-Based Study. J Clin Neurol 2021;17:257-64. [PMID: 33835747 DOI: 10.3988/jcn.2021.17.2.257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Sharma A, Gankidi VR, Nizami I, Rohan R. QUADRIPARESIS - IT'S APPROACH AND MANAGEMENT IN THE ED. PIJR 2020. [DOI: 10.36106/paripex/9708058] [Reference Citation Analysis]
18 Arsenijević M, Berisavac I, Mladenović B, Stanarčević P, Jovanović D, Lavrnić D, Peric S. Rate of progression of Guillain-Barré syndrome is not associated with the short-term outcome of the disease. Ir J Med Sci 2021;190:357-61. [PMID: 32666503 DOI: 10.1007/s11845-020-02310-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lin J, Gao Q, Xiao K, Tian D, Hu W, Han Z. Efficacy of therapies in the treatment of Guillain-Barre Syndrome: a network meta-analysis.. [DOI: 10.1101/2020.06.03.20121780] [Reference Citation Analysis]
20 Kasemsap N, Vorasoot N, Kongbunkiat K, Tiamkao S, Chotmongkol V, Sawanyawisuth K, Panitchote A. The Epidemiology of Guillain-Barré syndrome in Thailand over 13 years (2005 – 2017): A nationwide population-based retrospective cohort study (Preprint).. [DOI: 10.2196/preprints.20599] [Reference Citation Analysis]
21 Meena P, Bhargava V, Rana DS, Bhalla AK, Gupta A, Malik M, Gupta A, Tiwari V. Tacrolimus-Associated Guillain-Barre Syndrome. Am J Ther 2020;28:e268-70. [PMID: 32091420 DOI: 10.1097/MJT.0000000000001096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Klimkin AV, Voitenkov VB, Skripchenko NV. Inflammatory demyelinating polyneuropathies in children. jour 2019;19:183-191. [DOI: 10.18821/1560-9561-2016-19-3-183-191] [Reference Citation Analysis]
23 Bölükbaşi F, Ersen G, Gündüz A, Karaali-Savrun F, Yazici S, Uzun N, Akalin MA, Kiziltan ME. Guillain-Barré Syndrome and Its Variants: Clinical Course and Prognostic Factors. Noro Psikiyatr Ars 2019;56:71-4. [PMID: 30911241 DOI: 10.5152/npa.2017.18091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Benedetti L, Briani C, Beronio A, Massa F, Giorli E, Sani C, Delia P, Artioli S, Sormani MP, Mannironi A, Tartaglione A, Mancardi GL. Increased incidence of axonal Guillain‐Barré syndrome in La Spezia area of Italy: A 13‐year follow‐up study. J Peripher Nerv Syst 2019;24:80-86. [DOI: 10.1111/jns.12292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
25 Köhler W, Bien CG, Ehrlich S, Faiss J, Finke C, Gold R, Günther A, Harms L, Heigl F, Heine J, Hoffmann F, Janzen RWC, Jungehülsing GJ, Kieseier B, Kleiter I, Kraft A, Paul F, Prüß H, Schimrigk S, Sommer C, Stettner M, Trebst C, Tumani H. Konsensuspapier zum Einsatz der therapeutischen Apherese in der Neurologie. DGNeurologie 2019;2:15-33. [DOI: 10.1007/s42451-018-0051-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Hafsteinsdóttir B, Ólafsson E, Jakobsson F. Incidence and outcome of Guillain-Barré syndrome in Iceland: A population-based study. Acta Neurol Scand 2018;138:454-8. [PMID: 30019469 DOI: 10.1111/ane.13000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barré syndrome. Hum Vaccin Immunother 2018;14:2568-79. [PMID: 29953326 DOI: 10.1080/21645515.2018.1493415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
28 Altaweel YA, Abdelaziz S, Fathy HA, AbdelBadea S. Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome. Egypt J Neurol Psychiatr Neurosurg 2018;54:4. [PMID: 29780224 DOI: 10.1186/s41983-018-0006-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barré syndrome not determined by treatment options? Oncotarget 2017;8:79991-80001. [PMID: 29108381 DOI: 10.18632/oncotarget.20620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
30 Nayak R. Practical approach to the patient with acute neuromuscular weakness. World J Clin Cases 2017; 5(7): 270-279 [PMID: 28798922 DOI: 10.12998/wjcc.v5.i7.270] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
31 Singh S, Gultekin SH. Spinal Cord. Neuropathologic and Neuroradiologic Correlations 2017. [DOI: 10.1017/9781139696401.016] [Reference Citation Analysis]
32 Bidkar PU. Guillain–Barré syndrome. Manual of Neuroanesthesia 2017. [DOI: 10.1201/9781315154367-63] [Reference Citation Analysis]
33 Taylor CJ, Hirsch NP, Kullmann DM, Howard RS. Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period. J Neurol 2017;264:564-9. [PMID: 28091723 DOI: 10.1007/s00415-016-8380-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
34 Jasti AK, Selmi C, Sarmiento-monroy JC, Vega DA, Anaya J, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Review of Clinical Immunology 2016;12:1175-1189. [DOI: 10.1080/1744666x.2016.1193006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
35 Yoshida M, Ikeda J, Urikane Y, Kashiwada T, Kaseda Y, Kohriyama T. Prevalence of Tracheotomy and Percutaneous Endoscopic Gastrostomy in Patients with Guillain-Barré Syndrome. Dysphagia 2017;32:236-40. [PMID: 27687522 DOI: 10.1007/s00455-016-9750-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 do Rosário MS, de Jesus PA, Vasilakis N, Farias DS, Novaes MA, Rodrigues SG, Martins LC, Vasconcelos PF, Ko AI, Alcântara LC, de Siqueira IC. Guillain-Barré Syndrome After Zika Virus Infection in Brazil. Am J Trop Med Hyg 2016;95:1157-60. [PMID: 27645785 DOI: 10.4269/ajtmh.16-0306] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
37 Sung EJ, Kim DY, Chang MC, Ko EJ. Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome. Ann Rehabil Med 2016;40:481-8. [PMID: 27446785 DOI: 10.5535/arm.2016.40.3.481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Saad K, Mohamad IL, Abd El-Hamed MA, Tawfeek MS, Ahmed AE, Abdel Baseer KA, El-Shemy AS, El-Houfey AA, Tamer DM. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt. Ther Adv Neurol Disord 2016;9:3-8. [PMID: 26788127 DOI: 10.1177/1756285615610471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
39 Kutepov DE, Litvinov NI. Guillain-Barre syndrome. Kazan Med J 2015;96:1027-1034. [DOI: 10.17750/kmj2015-1027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Bangalore Raja SK, Kothandapani S, Noroozpour Z, Aheta Sham M, Prasad N, Sunny SP, Mohammed MD, Gangadharappa R, Nidsale Sudarshan R. Guillain-Barré syndrome: clinical profile and management. Ger Med Sci 2015;13:Doc16. [PMID: 26421004 DOI: 10.3205/000220] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
41 McLean NA, Popescu BF, Gordon T, Zochodne DW, Verge VM. Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves. PLoS One 2014;9:e110174. [PMID: 25310564 DOI: 10.1371/journal.pone.0110174] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
42 Tassart G, Balbeur S, Deltombe T, Tintillier M, Cuvelier Ch. Guillain-Barré syndrome associated with Puumula Hantavirus infection. Acta Clin Belg 2014;69:371-4. [PMID: 25092197 DOI: 10.1179/0001551214Z.00000000085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014;10:469-82. [DOI: 10.1038/nrneurol.2014.121] [Cited by in Crossref: 525] [Cited by in F6Publishing: 556] [Article Influence: 58.3] [Reference Citation Analysis]
44 Khazeni N, Hutton DW, Collins CI, Garber AM, Owens DK. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Ann Intern Med 2014;160:684-94. [PMID: 24842415 DOI: 10.7326/M13-2071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
45 Charra B, Hachimi A, Benslama A, Motaouakkil S. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome. Pan Afr Med J 2014;18:35. [PMID: 25368724 DOI: 10.11604/pamj.2014.18.35.2911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
46 Gutierrez A, Sumner AJ. Electromyography in neurorehabilitation. Textbook of Neural Repair and Rehabilitation 2014. [DOI: 10.1017/cbo9780511995590.010] [Reference Citation Analysis]
47 Technology of neurorehabilitation: outcome measurement and diagnostic technology. Textbook of Neural Repair and Rehabilitation 2014. [DOI: 10.1017/cbo9780511995590.003] [Reference Citation Analysis]
48 Boesch RP, Sawnani H. Neuromuscular Respiratory Failure. Pediatric Critical Care Medicine 2014. [DOI: 10.1007/978-1-4471-6356-5_16] [Reference Citation Analysis]
49 Harms M. Inpatient management of guillain-barré syndrome. Neurohospitalist 2011;1:78-84. [PMID: 23983841 DOI: 10.1177/1941875210396379] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
50 Suzuki M. Peripheral neuropathy in the elderly. Handb Clin Neurol 2013;115:803-13. [PMID: 23931816 DOI: 10.1016/B978-0-444-52902-2.00046-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
51 Fujimura H. The Guillain-Barré syndrome. Handb Clin Neurol 2013;115:383-402. [PMID: 23931791 DOI: 10.1016/B978-0-444-52902-2.00021-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
52 Akbayram S, Doğan M, Akgün C, Peker E, Sayιn R, Aktar F, Bektaş MS, Caksen H. Clinical features and prognosis with Guillain-Barré syndrome. Ann Indian Acad Neurol 2011;14:98-102. [PMID: 21808470 DOI: 10.4103/0972-2327.82793] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
53 Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré Syndrome. Ann Indian Acad Neurol 2011;14:262-6. [PMID: 22346014 DOI: 10.4103/0972-2327.91942] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
54 von Geldern G, McPharlin T, Becker K. Immune mediated diseases and immune modulation in the neurocritical care unit. Neurotherapeutics 2012;9:99-123. [PMID: 22161307 DOI: 10.1007/s13311-011-0096-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
55 Baker MG, Kvalsvig A, Zhang J, Lake R, Sears A, Wilson N. Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010. Emerg Infect Dis 2012;18:226-33. [PMID: 22304786 DOI: 10.3201/eid1802.111126] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
56 Bos Eyssen ME, van Doorn PA, Jacobs BC, Steyerberg EW, van der Voort PH, Zandstra DF, Horn J, Spronk PE, Hoedemaekers CW, Bakker J, van der Jagt M. Selective digestive tract decontamination decreases time on ventilator in Guillain-Barré syndrome. Neurocrit Care 2011;15:128-33. [PMID: 21468781 DOI: 10.1007/s12028-011-9536-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
57 Huan M, Smith AG. Weakness (Guillain–Barré Syndrome). Emergency Neurology 2012. [DOI: 10.1007/978-0-387-88585-8_12] [Reference Citation Analysis]
58 Meena AK, Khadilkar SV, Murthy JM. Treatment guidelines for Guillain-Barré Syndrome. Ann Indian Acad Neurol 2011;14:S73-81. [PMID: 21847334 DOI: 10.4103/0972-2327.83087] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
59 Grimaldi-Bensouda L, Alpérovitch A, Besson G, Vial C, Cuisset JM, Papeix C, Lyon-Caen O, Benichou J, Rossignol M; Lucien Abenhaim for the GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011;174:326-35. [PMID: 21652600 DOI: 10.1093/aje/kwr072] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
60 El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study. Crit Care 2011;15:R164. [PMID: 21745374 DOI: 10.1186/cc10305] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
61 Yerdelen D, Kucukgoz U, Karatas M. Association between acute motor axonal neuropathy and ophthalmoplegia during pregnancy. J Clin Neurosci 2011;18:999-1000. [PMID: 21565505 DOI: 10.1016/j.jocn.2010.11.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
62 Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology 2011;76:968-75. [PMID: 21403108 DOI: 10.1212/WNL.0b013e3182104407] [Cited by in Crossref: 174] [Cited by in F6Publishing: 178] [Article Influence: 14.5] [Reference Citation Analysis]
63 Zuccoli G, Panigrahy A, Bailey A, Fitz C. Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol 2011;32:639-42. [PMID: 21292802 DOI: 10.3174/ajnr.A2358] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
64 August KG, Guidali M, Sellathurai M, Jenu S, Bleichenbacher D, Klamroth-marganska V, Adamovich SV, Riener R. A system for sensory motor rehabilitation of the upper limb with virtual reality, exoskeleton robot, and real objects. 2011 IEEE Conference on Technologies for Practical Robot Applications 2011. [DOI: 10.1109/tepra.2011.5753482] [Reference Citation Analysis]
65 Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33. [PMID: 21422765 DOI: 10.1159/000324710] [Cited by in Crossref: 490] [Cited by in F6Publishing: 514] [Article Influence: 40.8] [Reference Citation Analysis]
66 Soysal A, Aysal F, Caliskan B, Dogan Ak P, Mutluay B, Sakalli N, Baybas S, Arpaci B. Clinico-electrophysiological findings and prognosis of Guillain-Barré syndrome--10 years' experience. Acta Neurol Scand 2011;123:181-6. [PMID: 20497128 DOI: 10.1111/j.1600-0404.2010.01366.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
67 Simmons Z. Treatment and Management of Autoimmune Neuropathies. Neuromuscular Disorders: Treatment and Management. Elsevier; 2011. pp. 215-35. [DOI: 10.1016/b978-1-4377-0372-6.00014-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Khazeni N, Hutton DW, Garber AM, Owens DK. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med 2009;151:840-53. [PMID: 20008760 DOI: 10.7326/0003-4819-151-12-200912150-00156] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
69 Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 2009;151:829-39. [PMID: 20008759 DOI: 10.7326/0003-4819-151-12-200912150-00157] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
70 Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 2009;151:829-39. [PMID: 20008759 DOI: 10.7326/0003-4819-151-12-200912150-00157] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
71 Anthony DC, Frosch MP, De Girolami U. Peripheral Nerve and Skeletal Muscle. Robbins and Cotran Pathologic Basis of Disease 2010. [DOI: 10.1016/b978-1-4377-0792-2.50032-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Sünkeler I. Epidemiologie neurologisch bedingter Behinderungen. NeuroRehabilitation 2010. [DOI: 10.1007/978-3-642-12915-5_4] [Reference Citation Analysis]
73 Pountney D. Identifying and managing Guillain-Barré syndrome. British Journal of Neuroscience Nursing 2009;5:381-383. [DOI: 10.12968/bjnn.2009.5.8.43600] [Reference Citation Analysis]
74 Battin MP, Francis LP, Jacobson JA, Smith CB. The Patient as Victim and Vector View as Critical and Diagnostic Tool. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0021] [Reference Citation Analysis]
75 . PREFACE. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.002.0005] [Reference Citation Analysis]
76 Battin MP, Francis LP, Jacobson JA, Smith CB. A Thought Experiment. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0015] [Reference Citation Analysis]
77 Battin MP, Francis LP, Jacobson JA, Smith CB. From the Magic Mountain to a Dying Homeless Man and His Dog:. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0009] [Reference Citation Analysis]
78 Battin MP, Francis LP, Jacobson JA, Smith CB. The Biological Basics of Infectious Disease. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0002] [Reference Citation Analysis]
79 Battin MP, Francis LP, Jacobson JA, Smith CB. Embedded Autonomy and the “Way-Station Self”. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0006] [Reference Citation Analysis]
80 Battin MP, Francis LP, Jacobson JA, Smith CB. Closing The Book on Infectious Disease. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0005] [Reference Citation Analysis]
81 Battin MP, Francis LP, Jacobson JA, Smith CB. Should Rapid Tests for Hiv Infection Now Be Mandatory During Pregnancy or In Labor? The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0012] [Reference Citation Analysis]
82 Battin MP, Francis LP, Jacobson JA, Smith CB. Antimicrobial Resistance. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0013] [Reference Citation Analysis]
83 . Copyright Page. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.002.0003] [Reference Citation Analysis]
84 Battin MP, Francis LP, Jacobson JA, Smith CB. How Infectious Disease Got Left Out of Bioethics. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0004] [Reference Citation Analysis]
85 Battin MP, Francis LP, Jacobson JA, Smith CB. Thinking Big. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0020] [Reference Citation Analysis]
86 Battin MP, Francis LP, Jacobson JA, Smith CB. Compensation and the Victims of Constraint. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0018] [Reference Citation Analysis]
87 Battin MP, Francis LP, Jacobson JA, Smith CB. Immunization and the Hpv Vaccine. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0014] [Reference Citation Analysis]
88 Battin MP, Francis LP, Jacobson JA, Smith CB. Pandemic Planning. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Battin MP, Francis LP, Jacobson JA, Smith CB. The Multiple Perspectives of the Patient as Victim and Vector View. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Battin MP, Francis LP, Jacobson JA, Smith CB. Pandemic Planning and the Justice of Health-Care Distribution. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0019] [Reference Citation Analysis]
91 Battin MP, Francis LP, Jacobson JA, Smith CB. The Patient as Victim and Vector. 2009. [DOI: 10.1093/acprof:oso/9780195335842.001.0001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
92 Battin MP, Francis LP, Jacobson JA, Smith CB. Characteristics of Infectious Disease That Raise Distinctive Challenges for Bioethics. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Battin MP, Francis LP, Jacobson JA, Smith CB. Constraints in the Control of Infectious Disease. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0016] [Reference Citation Analysis]
94 Battin MP, Francis LP, Jacobson JA, Smith CB. Seeing Infectious Disease as Central. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0001] [Reference Citation Analysis]
95 Battin MP, Francis LP, Jacobson JA, Smith CB. Old Wine in New Bottles:. The Patient as Victim and Vector 2009. [DOI: 10.1093/acprof:oso/9780195335842.003.0008] [Reference Citation Analysis]
96 Hahn CD, Banwell BL. Diseases of the Peripheral Nervous System. The Central Nervous System in Pediatric Critical Illness and Injury 2009. [DOI: 10.1007/978-1-84800-993-6_12] [Reference Citation Analysis]
97 Chiò A, Cocito D, Bottacchi E, Buffa C, Leone M, Plano F, Mutani R, Calvo A; PARCIDP. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry 2007;78:1349-53. [PMID: 17494979 DOI: 10.1136/jnnp.2007.114868] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 6.2] [Reference Citation Analysis]
98 Markoula S, Giannopoulos S, Sarmas I, Tzavidi S, Kyritsis AP, Lagos G. Guillain-Barré syndrome in northwest Greece. Acta Neurol Scand 2007;115:167-73. [PMID: 17295711 DOI: 10.1111/j.1600-0404.2006.00731.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
99 Sheppard CA, Hillyer CD. Therapeutic Apheresis. Consultative Hemostasis and Thrombosis 2007. [DOI: 10.1016/b978-141602401-9.10030-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Hiraga A, Mori M, Ogawara K, Kojima S, Kanesaka T, Misawa S, Hattori T, Kuwabara S. Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2005;76:719-22. [PMID: 15834034 DOI: 10.1136/jnnp.2004.051136] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 3.3] [Reference Citation Analysis]
101 Bogliun G, Beghi E; Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand 2004;110:100-6. [PMID: 15242417 DOI: 10.1111/j.1600-0404.2004.00272.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.1] [Reference Citation Analysis]